Medication info
Tenegly 20 mg (Teneligliptin Hydrobromide Hydrate)

Tenegly 20 mg (Teneligliptin Hydrobromide Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pink, round, film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102858 · Approved 2021.04.01 · Insurance code 671707020

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine as monotherapy or in combination therapy is 20 mg once daily. It may be taken with or without food. When coadministered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This drug is used to help improve blood sugar control in patients with type 2 diabetes who are following a dietary and exercise regimen. It can be administered alone or in combination with other medications to enhance blood sugar management. Therefore, it is an effective treatment for improving blood sugar control.

How to take

Adult dose

The recommended dose of this medicine as monotherapy or in combination therapy is 20 mg once daily. It may be taken with or without food. When coadministered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.

Precautions

This drug should not be administered to patients with hypersensitivity to the active ingredient or other components. It is not appropriate for use in patients with diabetic ketoacidosis, diabetic coma, or pre-comatose states, or in patients with type 1 diabetes. It is also not suitable for patients with severe infections, or those who have had major surgery or severe trauma. Patients with severe liver dysfunction should use this drug with caution, as there is insufficient clinical experience. Patients with mild to moderate heart failure should use this drug carefully, and it is not recommended for patients with severe heart failure. Patients being treated with sulfonylureas or insulin are at risk of hypoglycemia, so caution is necessary. Patients with pituitary insufficiency, adrenal insufficiency, malnutrition, irregular eating habits, weakness, excessive alcohol intake, or those who have engaged in strenuous exercise are at a higher risk of hypoglycemia and should take care. This drug should be administered with caution to patients with a history of abdominal surgery or bowel obstruction. It is advisable to avoid this drug in patients with heart diseases that can cause QT interval prolongation or have a related history. Acute pancreatitis symptoms may occur, so if persistent severe abdominal pain or vomiting occurs, medical attention should be sought immediately. This drug may cause hypoglycemia, especially when combined with other diabetes medications, increasing the risk of hypoglycemia; therefore, patients need to be well-informed about hypoglycemic symptoms and how to manage them. Hypoglycemic symptoms can include dizziness, trembling, headache, and fatigue; when symptoms occur, foods containing sugar should be consumed. Serious side effects such as liver dysfunction, interstitial pneumonia, skin disorders, and acute pancreatitis can occur. Patients should consult a healthcare professional if any abnormal symptoms arise. Use of this drug is not recommended for pregnant or breastfeeding women; careful judgment is needed if used. Safety and effectiveness in pediatric patients have not been established, so it should not be used in children. Elderly patients may have decreased physical function, so their condition should be carefully monitored during administration. While no serious adverse effects have been reported with overdose, general emergency treatment and monitoring are required. This drug may interact with certain medications; patients should inform their healthcare professionals if they are taking other medications. Particularly, caution is needed when taken in conjunction with insulin, sulfonylureas, certain antifungals, and antiarrhythmic medications. During treatment with this drug, patients should be attentive to hypoglycemic symptoms and exercise caution when performing hazardous tasks such as driving or operating machinery. Additionally, if severe joint pain or blistering skin conditions occur, treatment should be discontinued immediately and consultation with a physician should take place.

Side effects

Hypoglycemia, constipation, bowel obstruction, liver dysfunction, interstitial pneumonia, similar pemphigus, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colon polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, loss of appetite, elevated amylase, elevated lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), elevated serum potassium levels, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, dyslipidemia, herpes zoster, limb pain, epigastric pain, gastritis, dizziness, upper respiratory infection, headache, dyspepsia, chronic gastritis, irritable bowel syndrome, fatigue, tremors, weakness, hunger, facial edema, nausea, viral upper respiratory infection, rhinitis, cold sweat, pruritus, diabetic retinopathy, visual impairment, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophil count, abnormal blood glucose, increased blood glucose, increased blood pressure, IV stage unspecified cell-type lung carcinoma, colon cancer, small intestine adenocarcinoma, malignant lung neoplasm, benign parathyroid tumor, gum cancer, prostate cancer, metastatic thyroid cancer, hepatic coma, lumbar spinal canal stenosis, intravertebral disc protrusion, intravertebral disc disorder, spinal ligament ossification, spinal foraminal stenosis, rotator cuff syndrome, bladder mass, ureteral calculi, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyp, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, urticaria, sensory disturbance, sensory loss, tension headache, peripheral neuropathy, facial paralysis, sciatica, positional dizziness, muscle weakness, back pain, limb pain, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasms, foot deformity, hypertrophic osteoarthropathy, bursitis, spinal osteoarthritis, postmenopausal osteoporosis, chest discomfort, fever, chills, generalized edema, injection site inflammation, chest pain, ureteral calculi, dysuria, renal cyst, nocturia, depression, anxiety disorder due to underlying medical condition, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, bruise, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, iron deficiency anemia, food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at a temperature between 1 and 30 degrees Celsius. This helps to maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Pink, round, film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.